Preclinical Development of Novel Therapeutics Targeting Aging Mechanisms (with Audio Descriptions)

preview_player
Показать описание
NIA OSBR has issued a new, time-sensitive funding opportunity for small businesses working on novel therapeutics targeting fundamental mechanisms of aging (RFA-AG-21-026). This pre-application webinar provides an overview of the SBIR U44 funding announcement and discuss NIA’s critical focus areas and research priorities designed for the U44.

Date: August 27, 2020
Speakers: Todd Haim Ph.D., Chief, NIA OSBR; Chhanda Dutta, Ph.D., Chief, Clinical Gerontology Branch, NIA Division of Geriatrics and Clinical Gerontology; Rebecca Fuldner, Ph.D., Health Scientist Administrator, NIA Division of Aging Biology

  1. National Institute on Aging
  2. small business
  3. research and development
  4. Small Business Research
  5. Small Business Grants
  6. Small Business Funding
Рекомендации по теме
Preclinical Development of 1:11:25

Preclinical Development of Novel Therapeutics Targeting Aging Mechanisms (with Audio Descriptions)

Preclinical Development of 1:08:28

Preclinical Development of Novel Therapeutics Targeting Aging Mechanisms

NACFC 2022 | 1:59:13

NACFC 2022 | S21: Preclinical Assessment of Novel Genetic Therapies

Preclinical Evaluation of 0:48:20

Preclinical Evaluation of CAR T Immunotherapies Using Novel Animal Models [Webinar]

ADVANCE 2024: Advances 0:59:48

ADVANCE 2024: Advances in Preclinical Research For Sanfilippo

Preclinical evaluation of 0:27:15

Preclinical evaluation of novel OT-analogs for the potential treatment of social behavioral deficits

Stem Cell Clinical 0:47:00

Stem Cell Clinical Trials: Designing Preclinical Studies for First in Human Trials | Joy Cavagnaro

Lost in translation: 0:21:58

Lost in translation: learning from preclinical data | Gerry Davies

Clinical Trial Regulations 0:19:17

Clinical Trial Regulations for Clinical Development of Traditional Medicines

Preclinical Development: Early 0:27:06

Preclinical Development: Early Considerations for Different Molecule Types -Tina Rogers

Novel Approaches to 0:05:50

Novel Approaches to Hemophilia Gene Therapy in Preclinical Development

JK06, a biparatopic 0:01:15

JK06, a biparatopic ADC in preclinical development

[Webinar] Preclinical Evaluation 0:58:54

[Webinar] Preclinical Evaluation of CAR-T Immunotherapies Using Novel Animal Models (20220628）

Izokibep: Preclinical development 0:00:33

Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutrali... | RTCL.TV

The Bench to 0:51:20

The Bench to Bedside Series: Preclinical Cancer Research with Scintica

Drug discovery and 0:07:22

Drug discovery and development process

Zebrafish Models of 0:20:18

Zebrafish Models of TANGO2 deficiency for preclinical studies of TANGO2 Deficiency Disorder

Multimodal Preclinical Cancer 0:46:05

Multimodal Preclinical Cancer Imaging: Approaches and Novel Theranostics

Preclinical Research and 0:44:12

Preclinical Research and Development considerations fro Nanomedicine

[49] Targeting EGFR: 0:02:17

[49] Targeting EGFR: integration of novel therapeutics in the management of H&N cancer

Keynote Presentation Molecular 0:46:36

Keynote Presentation Molecular Pharmacology Profiling the Precursor to Preclinical Development

ALS Preclinical Drug 0:53:25

ALS Preclinical Drug Discovery and Therapy Development: Finally, Real Progress!

From preclinical to 0:28:04

From preclinical to clinical: Making drug development efficient thru community-based collaboration

Preclinical Modeling & 0:49:24

Preclinical Modeling & Therapeutics Core: Updates & Opportunities